A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases

Radiotherapy and Oncology

Volumn 111, Issue 1, 2014, Pages 52-58

  Rodrigues, George ^a,b   Warner, Andrew ^a   Zindler, Jaap ^c   Slotman, Ben ^c   Lagerwaard, Frank ^c  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain metastases; Predictive modeling; Recursive partitioning analysis; Regional failure control; Stereotactic radiosurgery

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BRAIN DYSFUNCTION; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER SIZE; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STEREOTACTIC RADIOSURGERY; TREATMENT FAILURE; AGE; ASSESSMENT OF HUMANS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GROSS TUMOR VOLUME; LINEAR ACCELERATOR; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; RECURSIVE PARTITIONING ANALYSIS; STATISTICAL ANALYSIS; WHOLE BRAIN RADIOTHERAPY; WORLD HEALTH ORGANIZATION PERFORMANCE STATUS; ADVERSE EFFECTS; BRAIN NEOPLASMS; MIDDLE AGED; PROCEDURES; RADIOSURGERY; RISK; SECONDARY;

AGED; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; RADIOSURGERY; RETROSPECTIVE STUDIES; RISK;

EID: 84902152991     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.11.015     Document Type: Article

References (26)

1. D.W. Andrews, C.B. Scott, and P.W. Sperduto et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
2. D. Rades, G. Bohlen, and A. Pluemer et al. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapyfor 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients Cancer 109 2007 2515 2521
3. M. Kocher, M. Maarouf, and M. Bendel et al. Linac radiosurgeryversus whole brain radiotherapy for brain metastases. A survival comparison basedon the RTOG recursive partitioning analysis Strahlenther Onkol 180 2004 263 267
4. H. Aoyama, H. Shirato, and M. Tago et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2006 2483 2491
5. H. Aoyama, M. Tago, and N. Kato et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone Int J Radiat Oncol Biol Phys 68 2007 1388 1395
6. E.L. Chang, J.S. Wefel, and K.R. Hess et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Lancet Oncol 10 2009 1037 1044
7. M.A. Chidel, J.H. Suh, and C.A. Reddy et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases Int J Radiat Oncol Biol Phys 47 2000 993 999
8. M. Kocher, R. Soffietti, and U. Abacioglu et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 2011 134 141
9. A. Pirzkall, J. Debus, and F. Lohr et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases J Clin Oncol 16 1998 3563 3569
10. D. Rades, J.D. Kueter, and D. Hornung et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases Strahlenther Onkol 184 2008 655 662
11. M.K. Shehata, B. Young, and B. Reid et al. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy Int J Radiat Oncol Biol Phys 59 2004 87 93
12. P.K. Sneed, K.R. Lamborn, and J.M. Forstner et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43 1999 549 558
13. J.M. Varlotto, J.C. Flickinger, and A. Niranjan et al. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases Int J Radiat Oncol Biol Phys 62 2005 1125 1132
14. D. Rades, and S.E. Schild Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? Strahlenther Onkol 188 2012 702 706
15. K.H. Peacock, and G.J. Lesser Current therapeutic approaches in patients with brain metastases Curr Treat Options Oncol 7 2006 479 489
16. R. Soffietti, M. Kocher, and U.M. Abacioglu et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results J Clin Oncol 31 2013 65 72
17. G. Rodrigues, J. Zindler, and A. Warner et al. Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion control Oncologist 18 2013 330 335
18. J.D. Zindler, G. Rodrigues, and C.J. Haasbeek et al. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery Radiother Oncol 106 2013 370 374
19. W.F. Verbakel, F.J. Lagerwaard, A.J. Verduin, S. Heukelom, B.J. Slotman, and J.P. Cuijpers The accuracy of frameless stereotactic intracranial radiosurgery Radiother Oncol 97 2010 390 394
20. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
21. A. Iasonos, D. Schrag, G.V. Raj, and K.S. Panageas How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 2008 1364 1370
22. D. Rades, L. Dziggel, and T. Haatanen et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases Int J Radiat Oncol Biol Phys 80 2011 1122 1127
23. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
24. S. Scoccianti, and U. Ricardi Treatment of brain metastases: review of phase III randomized controlled trials Radiother Oncol 102 2012 168 179
25. D. Rades, L. Dziggel, and V. Nagy et al. A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone Radiother Oncol 108 2013 123 127
26. S. Harth, Y. Abo-Madyan, and L. Zheng et al. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy Radiother Oncol 2013 pii: S0167-8140(13)00467-2